SEC Form 4 · accession 0001209191-15-036093
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Daly
Officer — EVP, Chief Commercial Officer
Period of report
Apr 23, 2015
Accepted (ET)
Apr 24, 2015 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2015 | M | 1,203 | $16.62 | A | 4,724 | D | |
| Common Stock | Apr 23, 2015 | M | 15,464 | $16.62 | A | 20,188 | D | |
| Common Stock | Apr 23, 2015 | M | 5,556 | $18.32 | A | 25,744 | D | |
| Common StockF1,F2,F3 | Apr 23, 2015 | S | 22,223 | $107.67 | D | 3,521 | D | |
| Common Stock | Apr 23, 2015 | M | 14,718 | $64.55 | A | 18,239 | D | |
| Common StockF1,F2,F3 | Apr 23, 2015 | S | 14,718 | $107.67 | D | 3,521 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $16.62 | Apr 23, 2015 | M | 1,203 | D | — | Oct 21, 2019 | Common Stock | 1,203 | 3,610 | D |
| Non-Qualified Stock Option (right to buy)F4 | $16.62 | Apr 23, 2015 | M | 15,464 | D | — | Oct 21, 2019 | Common Stock | 15,464 | 46,391 | D |
| Non-Qualified Stock Option (right to buy)F5 | $18.32 | Apr 23, 2015 | M | 5,556 | D | — | Feb 8, 2020 | Common Stock | 5,556 | 22,321 | D |
| Non-Qualified Stock Option (right to buy)F6 | $64.55 | Apr 23, 2015 | M | 14,718 | D | — | Jan 20, 2021 | Common Stock | 14,718 | 19,624 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F3Represents weighted average sale price. Actual sale prices ranged from $106.88 - $108.22.
- F4Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F5Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F6Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.